FDMT: Rasio rega marang bathi 4dmoleculartherapeutics.com

Tandha merek 4D Molecular Corp (FDMT)

4D Molecular Therapeutics attracts leading geneticists through a system of stock options and generous research funding within an academic culture. This chart of the current share price demonstrates a P/E ratio of -3.40. The business relies on the creation of precision viral capsids for targeted drug delivery to the heart and eyes, while patent protection of unique vectors eliminates pricing pressure from competitors.

FDMT - Rasio rega marang bathi 4D Molecular Therapeutics ing rentang 04.07.2022 - 16.11.2026

Rincian analitis perusahaan 4dmoleculartherapeutics.com (FDMT)

Ringkesan analisis perusahaan:4DMT
Barang utama 4D Molecular Therapeutics

4D Molecular Therapeutics occupies a high-tech biopharmaceutical niche, developing precision vectors for gene therapy. By analyzing the company's P/E trajectory, an investor assesses the ratio of market value to net income. This metric serves as an indicator of the asset's resilience to market shocks, determining the break point between fair value and panic selling. A technological moat in the form of "sniper" gene delivery provides the fundamental basis for long-term position retention.

Analisis perusahaan pesaing

tempus.com - Kapitalisasi marang bathi resik|Pangali P/E QGEN|Periode bali modal bisnis Isis Pharmaceuticals|Pangali P/E RGEN (repligen.com)|Rasio rega pasar marang bathi resik RNA (Avidity Biosciences, Inc.)|CRSP - Rasio rega marang bathi|Nilai perusahaan marang bathi resik WGS (GeneDx)|RARE: Pangali P/E|Beam Therapeutics Corp - Nilai perusahaan marang bathi resik|Koefisien rega marang bathi SRPT|twistbioscience.com (TWST) - Periode bali modal bisnis|Pangali P/E TXG|NTLA (Intellia) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Stoke STOK|BioLife (BLFS) - Kapitalisasi marang bathi|wavelifesciences.com - Pangali P/E|Kapitalisasi marang bathi resik MAZE|SION: Pangali P/E|PRME - Periode bali modal bisnis|Koefisien rega marang bathi TSHA|QURE - Rasio kapitalisasi marang bathi resik|Pangali P/E MGTX|Periode bali modal bisnis regenxbio.com|Pangali P/E SLDB (Solid Biosciences Inc)|OCGN: Pangali rega marang bathi|PACB - Rasio rega marang bathi|Benitec (BNTC) - Koefisien rega marang bathi|DSGN: Pangali P/E|RCKT: Rasio rega pasar marang bathi resik|Rasio rega marang bathi Lexeo Therapeutics, Inc.|Kapitalisasi marang bathi Korro Bio, Inc. KRRO|Pangali P/E EDIT|Periode bali modal bisnis Silence Therapeutics Corp|Rasio rega marang bathi proqr.com PRQR|CDXS - Koefisien rega marang bathi|SGMO - Rasio rega marang bathi|Rasio kapitalisasi marang bathi resik Nautilus Biotechnology, Inc. (NAUT)|MGX: Pangali P/E|Pangali rega marang bathi DTIL|GBIO (Generation Bio) - Pangali P/E|Pangali rega marang bathi BOLD (boundlessbio.com)|Koefisien rega marang bathi XCUR (exicuretx.com)|Celsion Corporation - Pangali rega marang bathi|Pangali P/E PHIO (phiopharma.com)|Pangali P/E Mustang Bio, Inc. MBIO|RNAZ: Koefisien rega marang bathi|BNGO (Bionano Genomics) - Pangali rega marang bathi|APDN: Pangali P/E|bluebird bio (BLUE) - Pangali P/E|Rasio rega marang bathi ImmunoPrecise Antibodies Ltd.|Kapitalisasi marang bathi Omega OMGA|Pangali P/E OMIC|RGLS - Kapitalisasi marang bathi|Syros Pharmaceuticals, Inc - Koefisien rega marang bathi|Periode bali modal bisnis Codex DNA (TBIO)|TCON - Rasio rega marang bathi|UBX: Rasio rega marang bathi